EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance

Marwa Talat Alhothali iD, Torsten Seemann iD, Patiyan Andersson, Norelle Sherry, Jeremy D Silver, Oscar C Howden, Mathilda Wilmot, Wendy Siryj, Mark G Veitch, Benjamin P Howden iD, Courtney R Lane iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01526-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Marwa Talat Alhothali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Au…. Hauptthemen laut MEDLINE: Bacteremia, Anti-Bacterial Agents, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterococcal bacteremia is a common healthcare-associated infection, associated with significant morbidity and mortality, with the emergence of vancomycin-resistant enterococci further complicating treatment and clinical outcomes. Despite this, long-term estimates of population-based incidence and antimicrobial resistance trends are limited. We aim to describe the burden of enterococcal bacteremia in Victoria, Australia (population 7.0 million), over a 35-year period. We conducted a retrospective analysis of laboratory-confirmed enterococcal bacteremia episodes voluntarily reported to the Victorian Hospital Pathogen Surveillance Scheme database from 1988 to 2022. Population-based incidence was estimated using inverse probability weighting to adjust for inconsistent hospital participation. Incidence per 10,000 hospital admissions was determined for the period 2011–2022. Antimicrobial resistance was calculated as the annual proportion of resistant isolates among all tested isolates. Overall, 11,157 enterococcal bacteremia episodes were identified, mainly Enterococcus faecalis ( n = 6,915, 61.9%) and Enterococcus faecium ( n = 3,558, 31.9%). Incidence increased from 10 by 2022. Incidence per 10,000 hospital admissions within Victoria has also increased from 2.8 in 2011 to 4 in 2022. Although E. faecalis remained mostly susceptible to tested antibiotics, E. faecium showed persistently high levels of vancomycin resistance, ranging from 50.7% ( n = 69/136) to 66.5% ( n = 139/209) over the past decade. Increasing incidence and high rates of vancomycin resistance among E. faecium highlight the ongoing clinical and public health challenge posed by enterococcal bacteremia. Applying statistical modeling to account for variability in hospital participation improves the certainty of incidence measures and strengthens the evidence for true increase in disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaAnti-Bacterial AgentsGram-Positive Bacterial InfectionsHumansIncidenceRetrospective StudiesVictoriaMicrobial Sensitivity TestsFemaleEnterococcus faeciumEnterococcus faecalisMaleMiddle AgedAgedAdultEnterococcusVancomycin

Stichwörter der Autor:innen

Enterococcus speciesantimicrobial resistancebacteremiainverse probability weightingvancomycin

Substanzen

Anti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia.
  • Centre for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia.
  • AMR Surveillance and Response Unit, Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia.
  • Statistical Consulting Centre, The University of Melbourne, Melbourne, Victoria, Australia.
  • Tasmanian Department of Health, Hobart, Tasmania, Australia.

ORCID-Profile: Marwa Talat Alhothali, Torsten Seemann, Benjamin P Howden, Courtney R Lane

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Alhothali, M. T., Seemann, T., Andersson, P., Sherry, N., Silver, J. D., Howden, O. C., Wilmot, M., Siryj, W., Veitch, M. G., Howden, B. P., & Lane, C. R. (2026). Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01526-25

Vancouver

Alhothali MT, Seemann T, Andersson P, Sherry N, Silver JD, Howden OC, et al. Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01526-25

BibTeX
@article{Alhothali2026,
  author = {Alhothali, Marwa Talat and Seemann, Torsten and Andersson, Patiyan and Sherry, Norelle and Silver, Jeremy D and Howden, Oscar C and Wilmot, Mathilda and Siryj, Wendy and Veitch, Mark G and Howden, Benjamin P and Lane, Courtney R},
  title = {Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01526-25}
}
Kostenlos starten →